Differential Molecular Transcriptomics and Underlying Biological Pathways between Smokers Lung Cancer (Small Cell Lung Carcinoma) in Comparison to Healthy Human Lung Cells
Cancer is a public health crisis affecting approximately 19.3 million globally annually. Lung cancer has the highest percentage of incidence and is responsible for 27% of cancer-related deaths. The lung cancer of prevalence in smokers is small-cell lung carcinoma. Lung cancer cells often exhibit altered gene expression patterns, compared to their normal counterparts. Yet this differential gene expression is not well understood. Herein, we investigated the differential expression of genes in small cell cancer cell lines compared to a healthy lung cell line that can lead to further insights into the proliferation, metastasis, and drug resistance of these lung cancer cells. Whole transcriptomic and small non-coding RNA sequencing was done by Next-generation sequencing (NGS) method, coupled with the Ingenuity Pathway Analysis (IPA) to decipher the core canonical pathways involved in these lung cancer cell-signaling mechanisms in disease pathophysiology. The findings of this investigation identified multiple genes and small non-coding tRNA/tRNA fragments that were differentially expressed, which thereby showed the possibility of potential diagnostic/prognostic and therapeutic targets. This important transcriptomic analysis can be a valuable tool for developing more effective treatment strategies for smokers lung cancer.
References
[1]
Cooper, G.M. and Hausman, R.E. (2009) The Cell: A Molecular Approach. 5th Edition, Sinauer Associates, 725-771.
[2]
Seyfried, T.N. and Huysentruyt, L.C. (2013) On the Origin of Cancer Metastasis. CriticalReviewsinOncogenesis, 18, 43-73. https://doi.org/10.1615/critrevoncog.v18.i1-2.40
[3]
Hanahan, D. (2022) Hallmarks of Cancer: New Dimensions. CancerDiscovery, 12, 31-46. https://doi.org/10.1158/2159-8290.cd-21-1059
[4]
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: ACancerJournalforClinicians, 61, 69-90. https://doi.org/10.3322/caac.20107
[5]
Gupta, S. (2022) Screening for Colorectal Cancer. Hematology/OncologyClinicsofNorthAmerica, 36, 393-414. https://doi.org/10.1016/j.hoc.2022.02.001
[6]
Jiang, B., Bao, L., He, S., Chen, X., Jin, Z. and Ye, Y. (2024) Deep Learning Applications in Breast Cancer Histopathological Imaging: Diagnosis, Treatment, and Prognosis. BreastCancerResearch, 26, Article No. 137. https://doi.org/10.1186/s13058-024-01895-6
[7]
Sen, T., Rodriguez, B.L., Chen, L., Corte, C.M.D., Morikawa, N., Fujimoto, J., et al. (2019) Targeting DNA Damage Response Promotes Antitumor Immunity through Sting-Mediated T-Cell Activation in Small Cell Lung Cancer. CancerDiscovery, 9, 646-661. https://doi.org/10.1158/2159-8290.cd-18-1020
[8]
Faber, A.C., Farago, A.F., Costa, C., Dastur, A., Gomez-Caraballo, M., Robbins, R., et al. (2015) Assessment of ABT-263 Activity across a Cancer Cell Line Collection Leads to a Potent Combination Therapy for Small-Cell Lung Cancer. ProceedingsoftheNationalAcademyofSciences, 112, E1288-E1296. https://doi.org/10.1073/pnas.1411848112
[9]
Hsu, W.H., Zhao, X., Zhu, J., Kim, I.K., Rao, G., et al. (2019) Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death. Journal of Thoracic Oncology, 14, 1032-1045.
[10]
Byers, L.A., Wang, J., Nilsson, M.B., Fujimoto, J., Saintigny, P., Yordy, J., et al. (2012) Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1. CancerDiscovery, 2, 798-811. https://doi.org/10.1158/2159-8290.cd-12-0112
[11]
Johnson, C.S., Costanzo-Garvey, D., Valencia, J.C., Rajgopal, S., Reed, T., Brannon, E.R., et al. (2025) Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer. MolecularCancerResearch, 23, 739-758. https://doi.org/10.1158/1541-7786.mcr-24-0672
[12]
Lin, D.W. (2015) Preface. UrologicClinicsofNorthAmerica, 42, xvii. https://doi.org/10.1016/j.ucl.2015.06.001
[13]
Yu, Y.C., Han, J.M. and Kim, S. (2021) Aminoacyl-tRNA Synthetases and Amino Acid Signaling. BiochimicaetBiophysicaActa (BBA)—MolecularCellResearch, 1868, Article ID: 118889. https://doi.org/10.1016/j.bbamcr.2020.118889
[14]
Jiang, L., Yu, L., Zhang, X., Lei, F., Wang, L., Liu, X., et al. (2016) Mir-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer. CancerResearch, 76, 1101-1111. https://doi.org/10.1158/0008-5472.can-15-1770
[15]
Lin, L. and Baehrecke, E.H. (2015) Autophagy, Cell Death, and Cancer. Molecular&CellularOncology, 2, e985913. https://doi.org/10.4161/23723556.2014.985913
[16]
Guo, S., He, X., Chen, Q., Yang, G., Yao, K., Dong, P., et al. (2017) The C-Reactive Protein/Albumin Ratio, a Validated Prognostic Score, Predicts Outcome of Surgical Renal Cell Carcinoma Patients. BMCCancer, 17, Article No. 171. https://doi.org/10.1186/s12885-017-3119-6
[17]
Alevizakos, M., Kaltsas, S. and Syrigos, K.N. (2013) The VEGF Pathway in Lung Cancer. CancerChemotherapyandPharmacology, 72, 1169-1181. https://doi.org/10.1007/s00280-013-2298-3
[18]
Terabe, M. and Berzofsky, J.A. (2004) Immunoregulatory T Cells in Tumor Immunity. CurrentOpinioninImmunology, 16, 157-162. https://doi.org/10.1016/j.coi.2004.01.010
[19]
Hakami, M.A., Hazazi, A., Abdulaziz, O., Almasoudi, H.H., Alhazmi, A.Y.M., Alkhalil, S.S., et al. (2024) HOTAIR: A Key Regulator of the Wnt/β-Catenin Signaling Cascade in Cancer Progression and Treatment. Pathology—ResearchandPractice, 253, Article ID: 154957. https://doi.org/10.1016/j.prp.2023.154957
[20]
Price, R.L., Bhan, A. and Mandal, S.S. (2021) HOTAIR Beyond Repression: In Protein Degradation, Inflammation, DNA Damage Response, and Cell Signaling. DNARepair, 105, Article ID: 103141. https://doi.org/10.1016/j.dnarep.2021.103141
[21]
Nishijima, N., Seike, M., Soeno, C., Chiba, M., Miyanaga, A., Noro, R., et al. (2016) Mir-200/ZEB Axis Regulates Sensitivity to Nintedanib in Non-Small Cell Lung Cancer Cells. InternationalJournalofOncology, 48, 937-944. https://doi.org/10.3892/ijo.2016.3331
[22]
Bieber, T. (2019) Interleukin-13: Targeting an Underestimated Cytokine in Atopic Dermatitis. Allergy, 75, 54-62. https://doi.org/10.1111/all.13954
[23]
Cheng, L., Zhou, M., Gu, Y., Chen, L. and Wang, Y. (2021) ZEB1: New Advances in Fibrosis and Cancer. MolecularandCellularBiochemistry, 476, 1643-1650. https://doi.org/10.1007/s11010-020-04036-7
[24]
Hodapp, S.J., Gravel, N., Kannan, N. and Newton, A.C. (2024) Cancer-Associated Mutations in Protein Kinase C Theta Are Loss-of-Function. BiochemicalJournal, 481, 759-775. https://doi.org/10.1042/bcj20240148
[25]
Wushou, A., Hou, J., Zhao, Y. and Shao, Z. (2014) Twist-1 Up-Regulation in Carcinoma Correlates to Poor Survival. InternationalJournalofMolecularSciences, 15, 21621-21630. https://doi.org/10.3390/ijms151221621
[26]
Chan, J.M., Quintanal-Villalonga, Á., Gao, V.R., Xie, Y., Allaj, V., Chaudhary, O., et al. (2021) Signatures of Plasticity, Metastasis, and Immunosuppression in an Atlas of Human Small Cell Lung Cancer. CancerCell, 39, 1479-1496.e18. https://doi.org/10.1016/j.ccell.2021.09.008
[27]
George, J., Lim, J.S., Jang, S.J., Cun, Y., Ozretić, L., Kong, G., et al. (2015) Comprehensive Genomic Profiles of Small Cell Lung Cancer. Nature, 524, 47-53. https://doi.org/10.1038/nature14664
[28]
Sen, T., Takahashi, N., Chakraborty, S., Takebe, N., Nassar, A.H., Karim, N.A., et al. (2024) Emerging Advances in Defining the Molecular and Therapeutic Landscape of Small-Cell Lung Cancer. NatureReviewsClinicalOncology, 21, 610-627. https://doi.org/10.1038/s41571-024-00914-x
